Embosphere微球栓塞治疗结肠癌肝转移的临床效果分析

Abstract
Figure/Table
References (0)
Related Citation (7)

Download: PDF (0 KB) HTML (35 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of Embosphere microspheres embolization in the treatment of liver metastases from colon cancer.Methods The clinical data and efficacy of 40 patients with liver metastases from colon cancer(the study group)from October 2014 to August 2016 in our hospital were retrospectively analyzed and compared with the 55 cases of liver metastasis of colon cancer patients accepted lipiodol treatment with the same period(the control group)in our hospital.The incidence rate of adverse reactions and the short-term efficacy of the two groups were compared.Results The disease remission rate and the disease control rate in the study group was higher than that in the control group,with significant difference (P＜0.05).There was no significant difference in the incidence rate of adverse reactions between the two groups(P＞0.05).Conclusion Short term efficacy of Embosphere microspheres embolization in the treatment of liver metastases from colorectal cancer is accurate,it has good clinical application value.

Key words： Colorectal cancer Liver metastase Embosphere microspheres Lipiodol Transcatheter arterial chemoembolization

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Meng
	GAO Zhong

Cite this article:

ZHANG Meng,GAO Zhong. Clinical effect analysis of Embosphere microspheres embolization in the treatment of liver metastases from colon cancer[J]. 中国当代医药, 2017, 24(5): 58-60.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I5/58

[1]	Kassahun WT.Unresolved issues and controversies surrounding the management of colorectal cancer liver metastasis[J]. World J Surg Onc，2015，13（1）：61.
[2]	皋文君，刘砚燕，袁长蓉.国际肿瘤化疗药物不良反应评价系统：通用不良反应术语标准4.0版[J].肿瘤，2012，32（2）：142-144.
[3]	Lencioni R，Llovet JM.Modified RECIST（mRECIST）assessment for hepatocellular carcinoma[J].Semin Liver Dis，2010，30（1）：52-60.
[4]	武中林，吴勇超，谷铁树，等.肝转移瘤血液供应来源分析[J].河北医科大学学报，2015，36（4）：428-432.
[5]	韩国宏，帖君.转移性肝癌的介入治疗[J].中华消化外科杂志，2014，13（3）：171-174.
[6]	简乾洪，郑方荣，阎雄.经肝动脉化疗栓塞术治疗结直肠癌肝转移的研究进展[J].临床肝胆病杂志，2016，32（6）：1216-1219.
[7]	Hashimoto Y，Sasaki Y，Yokoyama S，et al.A long-term survivor of a rectal carcinoid treated by use of repeat TACE for multiple intrahepatic recurrences after liver resection and MCT[J].Gan To Kagaku Ryoho，2014，41（12）：2142-2144.
[8]	Suciu BA，Gurzu S，Marginean L，et al.Significant shrinkage of multifocal liver metastases and long-term survival in a patient with rectal cancer，after trans-arterial chemoembolization（TACE）[J].Medicine（Baltimore），2015，94（42）：e1848.
[9]	StutzM，Mamo，A，ValentiD，etal.Real-lifereportonchemoembolization using DEBIRI for liver metastases from colorectal cancer[J].Gastroent Res Parct，2015，2015：715102.
[10]	王磊，宋卫华，龚少娟，等.Embosphere微球化疗栓塞治疗中晚期肝癌的临床疗效的前瞻性研究[J].肝胆外科杂志，2013，21（5）：329-333.
[11]	邵海波，张曦彤，李红，等.栓塞微球在肝癌介入治疗中的应用[J].介入放射学杂志，2008，17（11）：776-778.
[12]	陈红栓，白旭明，程龙，等.栓塞微球联合碘化油化疗栓塞治疗肝癌的临床研究[J].实用医学影像杂志，2012，13（4）：266-269.
[13]	陈燕浩，李家平，谭国胜，等.三丙烯微球联合碘化油治疗原发性肝细胞癌疗效探索[J].实用医学杂志，2014，30（2）：290-292.
[14]	Fiorentini G，Aliberti C，Turrisi G，et al.Intraarterial hepatic chemoembolization of liver metastases fromcolorectal cancer adopting irinotecan-eluting beads：results of a phaseⅡclinical study[J].In Vivo，2007，21（6）：1085-1091.
[15]	Poggi G，Quaretti P，Minoia C，et al.Transhepatic arterialchemoembolization with oxaliplatin-eluting microspheres（OEM-TACE）for unresectable hepatic tumors[J].Anticancer Res，2008，28（6）：3835-3842.
[16]	Martin RC，Joshi J，Robbins K，et al.Transarterial chemoembolization of metastatic colorectal carcinoma with drug-eluting beads，irinotecan（DEBIRI）：multi-institutional registry[J].J Oncol，2009，20（9）：539795.
[17]	Cao G，Zhu X，Li J，et al.A comparative study between Embosphere and conventional transcatheter arterial chemoembolization for treatment of unresectable liver metastasis from GIST[J].Chin J Cancer Res，2014，26（1）：124-131.